HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$1.74
Day range
$1.70 - $1.85
Year range
$1.43 - $6.85
Market cap
30.37M USD
Avg Volume
233.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | 183.92K | 21.58% |
Operating expense | 2.87M | 123.39% |
Net income | -2.70M | -129.26% |
Net profit margin | -1.47K | -88.57% |
Earnings per share | — | — |
EBITDA | -2.66M | -139.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.12M | 300.58% |
Total assets | 9.79M | 170.04% |
Total liabilities | 399.72K | 57.34% |
Total equity | 9.39M | — |
Shares outstanding | 17.55M | — |
Price to book | 3.11 | — |
Return on assets | -72.09% | — |
Return on capital | -77.67% | — |
Cash Flow
Net change in cash
| (USD) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | -2.70M | -129.26% |
Cash from operations | -2.73M | -130.70% |
Cash from investing | -37.80K | 5.55% |
Cash from financing | 4.35M | 138.84% |
Net change in cash | 1.58M | 162.16% |
Free cash flow | -1.75M | -120.42% |
About
Founded
2004
Website
Employees
7
